Our pharmaceutical pilot batch manufacturing service<\/strong><\/h1><\/div><\/div><\/div><\/div>The manufacture of pilot batches<\/strong> is an essential stage in the development of any new drug. CDM Lavoisier, an expert in pharmaceutical contract manufacturing<\/a>, puts its know-how at the service of pharmaceutical companies to support them at this stage, offering them customized, high-performance solutions. Every year, our company manufactures hundreds of batches of injectable drugs, both pilot and industrial sizes, in glass vials as well as glass and plastic ampoules.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div>![\"GMP](\"https:\/\/www.lavoisier.com\/wp-content\/uploads\/2021\/11\/GMP-CDM-Lavoisier.jpg\" "\\"GMP")
<\/span><\/div><\/div><\/div><\/div><\/div>What is a pilot batch?<\/h2><\/h2><\/div>A pilot batch is smaller than a standard industrial batch. Usually, the size of a pilot batch will represent 10% of an industrial batch. For instance, if an industrial batch contains 100,000 ampoules, the pilot batch will only contain 10,000. The pilot batch is often used as part of a drug development project<\/strong>.<\/p>\nThe production of a pilot batch meets several objectives :<\/p>\n
\n- trial batch to validate a manufacturing process ;<\/li>\n
- batch used for submission of a marketing authorization application ;<\/li>\n
- lot for the addition of a new industrial site as part of a technology transfer or a change of subcontractor ;<\/li>\n
- experimental or pre-production batches during formulation or industrial development stages.<\/li>\n<\/ul>\n
The importance of representativeness to the process<\/h2>\n
Whether pilot or industrial, each drug batch follows a particularly detailed manufacturing and control process<\/strong>. Representativeness of the industrial process means ensuring that the conditions and results obtained during small-scale production (as with a pilot batch) faithfully reflect those of large-scale production.<\/p>\nThe manufacture of the pharmaceutical pilot batch must reproduce the normal manufacturing conditions<\/strong> of an industrial batch, following the same constraints.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div>![\"Pharmaceutical](\"https:\/\/www.lavoisier.com\/wp-content\/uploads\/2021\/11\/Gamme-produits-et-services-CDM-Lavoisier.jpg\" "\\"Gamme")
<\/span><\/div><\/div><\/div><\/div><\/div>Pilot batch manufacturing steps<\/h2><\/div>The manufacturing steps for a pilot batch of injectable drugs are exactly the same as for an industrial batch<\/strong> :<\/p>\n\n- Sourcing of components and raw materials ;<\/li>\n
- Quality control of these components and raw materials ;<\/li>\n
- Solution preparation ;<\/li>\n
- Solution filling ;<\/li>\n
- Terminal sterilization with overheated water ;<\/li>\n
- In-process and finished product quality control ;<\/li>\n
- 100% visual inspection ;<\/li>\n
- Product packaging ;<\/li>\n
- Batch release ;<\/li>\n
- Traceability of operations in the batch file.<\/li>\n<\/ul>\n
The process strictly follows GMP standards (Good Manufacturing Practices). Pilot batches are often used to conduct stability studies<\/a> as part of the registration of a marketing authorization dossier or the submission of a variation for the addition of an industrial site.<\/p>\nOur factory has the necessary authorizations to manufacture a pilot batch :<\/p>\n
\n- EU-GMP<\/li>\n
- ISO 13485<\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div><\/div>
![\"Pharma](\"https:\/\/www.lavoisier.com\/wp-content\/uploads\/2023\/07\/Developpement-solutions-injectables-CDM-Lavoisier.jpg\" "\\"D\u00e9veloppement-solutions-injectables-CDM-Lavoisier\\"")
<\/span><\/div><\/div><\/div><\/div><\/div>Advantages and constraints of a small batch size<\/h2><\/div>For any manufacturer, profitability is often achieved through high production rates and large batch sizes. Nevertheless, the manufacture of small batches meets a major need<\/strong> in the pharmaceutical world. CDM Lavoisier can therefore manufacture batches from a few hundred to a few thousand units<\/strong> :<\/p>\n
The manufacture of pilot batches<\/strong> is an essential stage in the development of any new drug. CDM Lavoisier, an expert in pharmaceutical contract manufacturing<\/a>, puts its know-how at the service of pharmaceutical companies to support them at this stage, offering them customized, high-performance solutions. Every year, our company manufactures hundreds of batches of injectable drugs, both pilot and industrial sizes, in glass vials as well as glass and plastic ampoules.<\/p>\n<\/div> A pilot batch is smaller than a standard industrial batch. Usually, the size of a pilot batch will represent 10% of an industrial batch. For instance, if an industrial batch contains 100,000 ampoules, the pilot batch will only contain 10,000. The pilot batch is often used as part of a drug development project<\/strong>.<\/p>\n The production of a pilot batch meets several objectives :<\/p>\n Whether pilot or industrial, each drug batch follows a particularly detailed manufacturing and control process<\/strong>. Representativeness of the industrial process means ensuring that the conditions and results obtained during small-scale production (as with a pilot batch) faithfully reflect those of large-scale production.<\/p>\n The manufacture of the pharmaceutical pilot batch must reproduce the normal manufacturing conditions<\/strong> of an industrial batch, following the same constraints.<\/p>\n<\/div> The manufacturing steps for a pilot batch of injectable drugs are exactly the same as for an industrial batch<\/strong> :<\/p>\n The process strictly follows GMP standards (Good Manufacturing Practices). Pilot batches are often used to conduct stability studies<\/a> as part of the registration of a marketing authorization dossier or the submission of a variation for the addition of an industrial site.<\/p>\n Our factory has the necessary authorizations to manufacture a pilot batch :<\/p>\n For any manufacturer, profitability is often achieved through high production rates and large batch sizes. Nevertheless, the manufacture of small batches meets a major need<\/strong> in the pharmaceutical world. CDM Lavoisier can therefore manufacture batches from a few hundred to a few thousand units<\/strong> :<\/p>\n<\/span><\/div><\/div>What is a pilot batch?<\/h2><\/h2><\/div>
\n
The importance of representativeness to the process<\/h2>\n
<\/span><\/div><\/div>Pilot batch manufacturing steps<\/h2><\/div>
\n
\n
<\/span><\/div><\/div>Advantages and constraints of a small batch size<\/h2><\/div>
![\"CMO\"](\"https:\/\/www.lavoisier.com\/wp-content\/uploads\/2022\/01\/etude-stabilite.jpg\" "\\"etude-stabilite\\"")
<\/span><\/div><\/div>